Duckworth Questions Mylan CEO About EpiPens & Rx Drug Price Hikes
September 21, 2016
6,953
83
18
1.45%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Tammy Duckworth Episodes Around September 21, 2016
See what was published immediately before and after this episode.
6:29Now PlayingDuckworth Questions Mylan CEO About EpiPens & Rx Drug Price Hikes
YouTube Description
as posted by the channelCongresswoman Tammy Duckworth (IL-08) today challenged EpiPen distributor Mylan Pharmaceutical’s CEO Heather Bresch to explain her company’s outrageous price increases for their EpiPen auto-injector, a lifesaving medication countless parents rely on to keep their children alive during severe allergic reactions, as well as potentially illegal anticompetitive practices Mylan committed through its EpiPen4Schools program. Duckworth questioned Ms. Bresch during a House Oversight & Government Reform Committee hearing the Congresswoman called for earlier this month, after she also asked for a federal review antitrust of the company’s alleged illegal conduct.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.